The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects.
Chiu, Wei-Yih; Yang, Wei-Shiung; Chien, Jung-Yien; Lee, Jang-Jaer; Tsai, Keh-Sung.
; 13(4): e0196419, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29694412
Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ).
Medication-related osteonecrosis of the jaw: Surgical or non-surgical treatment?
Platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: a clinical and histopathological evaluation.
Issues with the surgical treatment of antiresorptive agent-related osteonecrosis of the jaws.
Treatment for bisphosphonate-related osteonecrosis of the jaw.
Knowledge of bisphosphonate-related osteonecrosis of the Jawsamong Mexican dentists.
Bisphosphonate Induced Osteonecrosis of the Jaws: Our Clinical Experience at King Hussein Medical Center, Amman, Jordan.
Alendronate-associated osteonecrosis of the jaws: a review of the main topics.
Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015.
Clinical impact of bisphosphonates in root canal therapy.